IP Library Granted Patent US 7,696,372
Granted Patent B2
US 7,696,372 · App. 12/285,291 · Granted Apr 13, 2010

Process for preparing R-gossypol L-phenylalaninol dienamine

Assignee: Ascenta Therapeutics, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,696,372
App. No.
12/285,291
Granted
Apr 13, 2010
Kind
B2
Abstract

This invention relates to a process for preparing R-gossypol L-phenylalaninol dienamine using non-chromatographic purification methods. In particular, the invention is directed to resolution of R- and S-gossypol L-phenylalaninol dienamine by crystallization. R-gossypol L-phenylalaninol dienamine is a useful intermediate for the preparation of R-(−)-gossypol and R-(−)-gossypol acetic acid co-crystal. R-(−)-Gossypol acetic acid and its co-crystal is useful for inducing apoptosis in cells and for sensitizing cells to the induction of apoptotic cell death.

Claims (40)

1. A process for preparing R-gossypol L-phenylalaninol dienamine from a mixture of R- and S-gossypol L-phenylalaninol dienamine comprising crystallizing said mixture from a solvent system comprising acetonitrile and water and isolating crystalline R-gossypol L-phenylalaninol dienamine substantially free from said S-gossypol L-phenylalaninol dienamine.

2. The process of claim 1 wherein said crystalline R-gossypol L-phenylalaninol dienamine is isolated by filtration.

3. The process of claim 1 wherein the acetonitrile:water ratio is about 5:1.

4. The process of claim 3 wherein the acetonitrile:water ratio is 5:1.

5. The process of claim 1 further comprising:

a) washing said crystalline R-gossypol L-phenylalaninol dienamine with a solvent system comprising acetonitrile and water; and

b) drying said crystalline R-gossypol L-phenylalaninol dienamine in vacuo.

6. A process for preparing R-gossypol L-phenylalaninol dienamine comprising:

a) condensing gossypol with L-phenylalaninol in acetonitrile to provide a mixture of R- and S-gossypol L-phenylalaninol dienamine;

b) adding water to the reaction mixture at the completion of a) to obtain crystallized R-gossypol L-phenylalaninol dienamine; and

c) isolating said crystalline R-gossypol L-phenylalaninol dienamine substantially free from said S-gossypol L-phenylalaninol dienamine.

7. The process of claim 6 wherein said crystalline R-gossypol L-phenylalaninol dienamine is isolated by filtration.

8. The process of claim 6 wherein the acetonitrile:water ratio in b) is about 5:1.

9. The process of claim 8 wherein the acetonitrile:water ratio is 5:1.

10. The process of claim 6 further comprising:

a) washing said crystalline R-gossypol L-phenylalaninol dienamine with a solvent system comprising acetonitrile and water; and

b) drying said crystalline R-gossypol L-phenylalaninol dienamine in vacuo.

11. The process of claim 1 or 6 wherein said crystallization is induced by seeding with crystalline R-gossypol L-phenylalaninol dienamine.

12. The process of claim 1 or 6 wherein said crystalline R-gossypol L-phenylalaninol dienamine has a purity of about 90% or more.

13. The process of claim 12 wherein said purity is about 95% or more.

14. The process of claim 13 wherein said purity is about 98% or more.

15. The process of claim 12 wherein said purity is about 99% or more.

16. In a process for preparing R-(−)-gossypol acetic acid co-crystals, the improvement comprising crystallizing a mixture of R- and S-gossypol L-phenylalaninol dienamine from a solvent system comprising acetonitrile and water and isolating crystalline R-gossypol L-phenylalaninol dienamine substantially free from said S-gossypol L-phenylalaninol dienamine; and preparing the R-(−)-gossypol acetic acid co-crystals.

17. The process of claim 16 , further comprising isolating said crystalline R-gossypol L-phenylalaninol dienamine by filtration.

18. The process of claim 16 , wherein the acetonitrile:water ratio is about 5:1.

19. The process of claim 18 , wherein the acetonitrile:water ratio is 5:1.

20. The process of claim 16 , further comprising:

a) washing said crystalline R-gossypol L-phenylalaninol dienamine with a solvent system comprising acetonitrile and water; and

b) drying said crystalline R-gossypol L-phenylalaninol dienamine in vacuo.

21. In a process for preparing R-(−)-gossypol acetic acid co-crystals, the improvement comprising:

a) condensing gossypol with L-phenylalaninol in acetonitrile to provide a mixture of R- and S-gossypol L-phenylalaninol dienamine;

b) adding water to the reaction mixture at the completion of a) to obtain crystallized R-gossypol L-phenylalaninol dienamine; and

c) isolating said crystalline R-gossypol L-phenylalaninol dienamine substantially free from said S-gossypol L-phenylalaninol dienamine; and

preparing the R-(−)-gossypol acetic acid co-crystals.

22. The process of claim 21 , further comprising isolating said crystalline R-gossypol L-phenylalaninol dienamine by filtration.

23. The process of claim 21 , wherein the acetonitrile:water ratio is about 5:1.

24. The process of claim 23 , wherein the acetonitrile:water ratio is 5:1.

25. The process of claim 21 , further comprising:

a) washing said crystalline R-gossypol L-phenylalaninol dienamine with a solvent system comprising acetonitrile and water; and

b) drying said crystalline R-gossypol L-phenylalaninol dienamine in vacuo.

Assignments (2)
RELEASE OF SECURITY INTEREST Recorded Sep 23, 2011
From: SILICON VALLEY BANK
To: ASCENTA THERAPEUTICS, INC.
Reel/Frame 026959/0131 →
SECURITY AGREEMENT Recorded Mar 15, 2010
From: ASCENTA THERAPEUTICS, INC.
To: SILICON VALLEY BANK, AS COLLATERAL AGENT AND AS A LENDER; OXFORD FINANCE CORPORATION, AS A LENDER
Reel/Frame 024085/0398 →
Continuity (3)
Provisional Application 6097663700 · Oct 1, 2007
Provisional Application 6112908200 · Jun 4, 2008
Related Publication 20090088590A1 · Apr 2, 2009